Life Sciences Archive » September, 2007

Life Sciences - September, 2007

158 articles

• Kraft Renews Battle Cry For Stay In P&G Feud
• Clinical Trial Patients Barely Protected By FDA: Study
• Canada Upholds Viagra Patent Over Apotex' Protests
• FDA Orders Halt To Unapproved Cough-Suppressants
• Planned Parenthood Stole Business Method: Suit
• Q&A With Faegre & Benson's Ken Liebman
• DOJ Fights Veterans' Health Care Reform Suit
• BMS, Apothecon Pay $515M To Settle Pricing Claims
• Immucor Lays SEC, Shareholder Actions To Rest
• Asbestos Victims Want Quigley President Out
• President Bush Signs Drug User Fee Bill
• Microsoft Ruling May Embolden Regulators: Experts
• Court Knocks Digene Down Again In HPV Suit
• Adams Respiratory Sues Perrigo Over Mucinex Patent
• Suit Against Isolagen, Underwriters Moves Forward
• Medtronic Vows To Appeal $226.3M Verdict
• Teva, Barr Win Transfer Of Aventis' Allegra Patent Suit
• Orthopedic Cos. Pay $311M To End Kickback Probe
• PTO Erred In Nixing Takeda's Double-Patent: Judge
• Drug Makers Prevail In Hormone Replacement Suit
• Punitive Damages Nixed In Accutane Suicide Case
• P&G Fights Kraft's Stay Bid In Coffee Packaging Spat
• Damages Back In Play In Pfizer Patent Suit
• Appeals Court Overturns $58M Ruling Against Vonage
• No Federal Jurisdiction For Zyprexa Suit: Montana
• Dietary Supplement Maker's Antitrust Suit Tossed
• AstraZeneca Asks For More Discovery Time
• Judge Hands Alaris More Money In Patent Suit
• Novartis Accused Of Forum Shopping In Lamisil Case
• FDA Warns Consumers About Pain Drug
• Pharmacogenomics And The "Learned Intermediary"
• Eli Lilly Pays $18M To Settle Contract Squabble
• Supreme Court Agrees To Hear Rezulin Case
• Utah AG Sues Slew Of Drug Cos. Over AWPs
• AstraZeneca Wants Seroquel, Zyprexa Plaintiffs' Docs
• Supreme Court To Tackle Patent Exhaustion
• Depomed Says Teva Unit Infringed Diabetes Patents
• Roche Fights To Protect Boniva Patent
• Becton Dickinson Balks At Discovery In Syringe MDL
• Barr Sued Over Chewable Contraceptive
• Cordis Cites Stent Risk But Still Loses Patent Fight
• Dr. Reddy's Wants Clarinex Claims Trimmed
• Dutch Pension Fund Files Amended Suit Over Vioxx
• Hogan & Hartson LLP
• Guidant Fights Health-Care Providers' Appeal Attempt
• House Bill Would Strengthen Food Import Laws
• FDA Defends Delays Over Vioxx Documents
• AWP Counsel Asks Court To Kick Haviland Law Firm
• Red Cross Fights Off J&J Suit Over Famous Mark
• Accutane Trial To Begin Monday, As Planned
• Pfizer Wins Appeal Over Neurontin
• Alza Makes Another Push For Data In Ditropan Case
• Environmental Guns Take Shot At Air Fresheners
• Novartis Drops Patent Claims Against Ranbaxy
• Cadwalader Forms New IP Group
• FDA Updates Warning Labels On Blockbuster Drugs
• House Approves FDA Drug User Fee Legislation
• Software Co. Sues Fanuc, GE Over Robot Patents
• Epstein Becker
• Actavis Claims Cancer Drug Patents Are Invalid
• Biotech Expert Becomes Dechert IP Partner
• Kraft Seeks Stay In P&G Coffee Packaging Spat
• Applera, Agilent Settle Genetic Research Patent Spat
• Bio-Rad Claims Infringment Of Microplate Patent
• Defibrillators Could Fail, Recall Warns
• Judge Greenlights Baycol Plaintiffs' Appeal
• FDA Claims Dirty Advertising Over P&G Sanitizer
• Orexigen, Duke, Eisai Strike Foreign IP Deal
• Bayer Seeks Stay In Tainted Blood Products Suit
• ICU Medical Prevails In IV Patent Dispute
• Abbott Shoots Down Government Complaint
• Cordis Stent Case May Be Consolidated
• Encysive Wins Dismissal Of Securities Suit
• New York Hits Merck With Another Vioxx Suit
• J&J, Angiotech Reach Accord Over Stent Patents
• J&J Asks Court To Resurrect Claim Against Abbott
• Apotex Bid To Overturn Prilosec Decision Denied
• Roche Files Third Suit This Month Over Boniva ANDAs
• Aredia Case Belongs In State Court: Magistrate Judge
• Merck Balks At Class Bid In Fosamax Case
• Pfizer Moves To Toss More Cases From Bextra MDL
• Judge Nixes Glaxo's Bid To Strike Paxil Testimony
• Certified Ortho-McNeil FLSA Class Expected To Swell
• Foley Hoag
• Improper Use Of Fentora Can Be Deadly: Cephalon VP
• 211 Plaintiffs Will Join Suit Against Merck Over FLSA
• Sanofi Plaintiffs Challenge Employee Declarations
• Orion sues Wockhardt Over Parkinson's Drug
• NuvaRing Plaintiffs Battle Organon Over Jurisdiction
• Judge Rejects Lipodissolve Ban
• Aventis To Face Whistleblower Claims Over Lovenox
• AstraZeneca Backs Up Call To Toss Seroquel Claims
• Canadian Court Upholds Lipitor In Crystal Form
• Before Settling, Guidant Plaintiffs Consider Appeal
• Sans Injunction, Open Season For Generic Protonix
• O'Melveny & Myers
• ASC Resists Alza's Bid For Ditropan Data
• Judge Sends Two AWP Cases Home
• Plaintiffs Deny Desire For Seal In Aredia Case
• Judge Upholds BofA Victory In Patent Suit
• CORRECTED: Judge Issues Ruling In Guidant Price Publishing Spat
• Big Pharmas Cite Elevator Ruling To Boost Case
• Two New Articles Add More Fuel To Avandia Fire
• Hogan & Hartson Lures FDA Attorney
• Airborne Suit Moved To Federal Court
• Pfizer Faces Swelling MDL Over Bextra, Celebrex
• Teva, Dr. Reddy's Settle Generic Zoloft Dispute
• Judge Tosses Some Claims In Merck Race Bias Suit
• Novo Nordisk Seeks To Halt Sanofi Insulin Pen
• Apotex Suffers Defeat In Acular Dispute
• AstraZeneca, Plaintiffs Spar Over Seroquel Expert
• McKool Smith Opens ITC-Focused D.C. Office
• Abbott, Feds Sound Off On AWP Ruling
• Judge Mulls Plaintiffs' Bid To Alter Mirapex Suit
• Ramipril Patent Invalid Due To Obviousness: Court
• Hoffman-La Roche Sues Teva Over Osteoporosis Drug
• Biovail Settles With BofA, Trader In Conspiracy Case
• Pfizer Seeks Dismissal Of Another Bextra Suit
• Glaxo Investors Vie For Lead Plaintiff Role
• ImClone To Pay $65M To End Erbitux Suit
• Sanofi-Aventis Pays $190M To Settle Drug Price Case
• Judge Blocks Sale Of Teva's Generic Famvir
• Becton, RTI Spar Over Syringe Patents, Competition
• Abbott Warns Of Faulty Glucose Monitors
• Abbott Fights Depositions Of Former Head Honchos
• Faegre & Benson
• Acacia Unit Targets Medical Tech Bigwigs
• Judge OKs Settlement In Drug Securities Case
• Judge Orders Plaintiffs To Respond In Accutane Case
• Supreme Changes in Patent Law
• Sanctions Urged In Celexa, Lexapro Case
• Eli Lilly Adds 9 Defendants To Strattera Suit
• House Ushers In New Era With Patent Reform Act
• Seroquel Plaintiffs Object To Dismissal Conversions
• Eli Lilly Settles With Doctor Over Zyprexa Leaks
• Par Calls Novartis' Lotrel Patent Unenforceable
• Enzo Appeals Loss In DNA Detection Patent Suit
• Glaxo Seeks To Bar Testimony In Paxil Case
• Nationwide Class For Vioxx Suit Rejected
• Novartis Rebuffs Claims In Aredia Case
• Judge Orders Vioxx Plaintffs To File Separate Claims
• J&J Unit Wants ASC To Turn Over Ditropan Docs
• Judge OKs Insider Trading Settlement In Drug Case
• Ortho-McNeil Spars With Makers Of Ultracet Generic
• Switching Cholesterol Drugs May Be Fatal: Study
• Ninth Circuit Remands Royalty Dispute Over Zilactin
• Lexapro Patent Upheld On Appeal
• Judge Allows Teva To Launch Generic Herpes Drug
• Schering, Employees To Face Off Over Benefit Plan
• AstraZeneca Seeks More Dismissals In Seroquel Case
• Greenberg Traurig Lures GlaxoSmithKline VP
• Pfizer Moves To Toss Fraud Claims In Mirapex Case
• Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs
• Allergan Sued Over Dry Eye Patent
• Reed Smith
• Dr. Reddy's Wants Teva's Coreg Claims Bounced
• Pharmexa Loses Bid To Restore Broad Patent Claims
• Judge Siphons Off Funds For Aredia Attorneys